Dates: Monday, November 9 and Tuesday, November 24
Time: 10 a.m. EST (15:00 UTC/GMT)
November 9: Register here
November 24: Register here
The World Federation of Hemophilia (WFH) will host two 60-minute informational webinars on the WFH Gene Therapy Registry, on November 9 and November 24, at 10 a.m. EST (15:00 UTC/GMT). The WFH Gene Therapy Registry is designed to collect long-term data on safety, and variability and durability of efficacy on all people with hemophilia (PWH) who receive gene therapy.
Webinar attendees will have a chance to hear Glenn Pierce, MD, PhD, WFH Vice President, Medical (U.S.A), Barbara Konkle, MD, (U.S.A.), and Wolfgang Miesbach, MD (Germany) discuss the following aspects of the WFH Gene Therapy Registry:
Presentations will be followed by a Q&A session.
We encourage you to submit questions in advance by emailing the WFH at [email protected], no later than November 6. Participants will also have the opportunity to ask questions during the session.